Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2002-12-18
2008-12-23
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S050000, C435S069100, C435S252300, C435S320100, C530S350000, C536S023700
Reexamination Certificate
active
07468185
ABSTRACT:
The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease.
REFERENCES:
patent: 4661350 (1987-04-01), Tsurumizu et al.
patent: 5536497 (1996-07-01), Evans et al.
patent: 6160087 (2000-12-01), Ogawa
patent: 6444799 (2002-09-01), Ross
patent: 61-140527 (1986-06-01), None
patent: WO 95/09181 (1995-04-01), None
patent: WO 95/10612 (1995-04-01), None
patent: WO 01/83530 (2001-11-01), None
Fournier et al 2001, International Journal of Systemic and Evolutionary Microbiology, vol. 51: 1179-1189.
Bailey et al 1995, International Journal of Systemic Bacteriology, vol. 45: 246-249.
Evans et al Infect Immun. 1992,60(7): 2926-2935.
Rumpf RW, et al , Clin Microbiol. Aug. 1999;37(8):2723-5.
J.Clin Microbiol. Mar. 2002; 40(3): 1044-1047.
Kesavalu L, Infect Immun. Apr. 1992;60(4):1455-64.
Dickinson D.P. et al., “Molecular Cloning and Sequencing of the Gene Encoding the Fimbrial Subunit Protein ofBacteroides gingivalis”, Journal of Bacteriology170(4):1658-1665 (1988).
Evans R.T. et al., “Immunization withPorphyromonas(Bacteroides)gingivalisFimbriae Protects against Periodontal Destruction”,Infection and Immunity60(7):2926-2935 (1992).
Collins M.D. et al., “Phylogenetic Analysis of Members of the GenusPorphyromonasand Description ofPorphyromonas cangingivalissp. nov. andPorphyromonas cansulcisp. nov.”,International Journal of Systematic Bacteriology44(4):674-679 (1994).
Harvey C.E. et al., “Subgingival Bacteria-Comparison of Culture Results in Dogs and Cats With Gingivitis”,J. Vet. Dent. 12(4):147-150 (1995).
Allaker R.P. et al., “Prevalence ofPorphyromonasandPrevotellaspecies in the dental plaque of dogs”The Veterinary Record 140(6):147-148 (1997).
Norris J.M. et al., “Associations amongst three felinePorphyromonasspecies from the gingival margin of cats during periodontal health and disease”,Veterinary Microbiology 65:195-207 (1999).
Sharma A. et al., “Oral Immunization with RecombinantStreptococcus gordoniiExpressingPorphyromonas gingivalisFimA Domains”,Infection and Immunity 69(5):2928-2934 (2001).
Ross B.C. et al., “Identification of vaccine candidate antigens from a genomic analysis ofPorphyromonas gingivalis”, Vaccine 19:4135-4142 (2001).
Carl R. Woese, “Bacterial Evolution,” Microbiological Reviews, Jun. 1987, vol. 51, No. 2, pp. 221-271.
Dreier Kimberly Jean
Hardham John Morgan
King Kendall Wayne
Krishnan Rajendra
McGavin David Ross
Baskar Padma V
Donahue E. Victor
Ling Lorraine B.
Mondesi Robert B
Pfizer Inc.
LandOfFree
Vaccine for periodontal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for periodontal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for periodontal disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4040781